RT Journal Article
SR Electronic
T1 Evaluation of RNA extraction free method for detection of SARS-COV-2 in salivary samples for mass screening for COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.15.21253570
DO 10.1101/2021.03.15.21253570
A1 Mahmoud, Sally A.
A1 Ibrahim, Esra
A1 Ganesan, Subhashini
A1 Thakre, Bhagyashree
A1 Teddy, Juliet G
A1 Raheja, Preeti
A1 Abbas, Walid Z
YR 2021
UL http://medrxiv.org/content/early/2021/03/17/2021.03.15.21253570.abstract
AB In this current COVID - 19 pandemic, there is a dire need for cost effective and less time-consuming alternatives for SARS-COV-2 testing. The RNA extraction free method for detecting SARS-COV-2 in saliva is a promising option, this study found that it has high sensitivity (85.34%), specificity (95.04%) and was comparable to the gold standard nasopharyngeal swab. The method showed good percentage of agreement (kappa coefficient) 0.797 between salivary and NPS samples. However, there are variations in the sensitivity and specificity based on the RT-PCR kit used. The Thermo Fischer-Applied biosystems showed high sensitivity, PPV and NPV but also showed higher percentage of invalid reports. Whereas the BGI kit showed high specificity, better agreement (kappa coefficient) between the results of saliva and NPS samples and higher correlation between the Ct values of saliva and NPS samples. Thus, the RNA extraction free method for salivary sample serves as an effective alternative for SARS-CoV 2-testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was not funded by any funding body, it was done in Biogenix lab as a part of researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics approval was obtained from Department of Health (DOH) Institutional review board (IRB), Abu Dhabi All methods were carried out in accordance with relevant guidelines and regulations. The Department Of Health (DOH) Institutional review board (IRB), Abu Dhabi written informed consent were obtained from all the participants All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available with the author, Dr. Sally, Director of Biogenix G42 lab and will be produced on request